Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular 'Direct‐to‐Biology' Screening.

Saved in:
Bibliographic Details
Title: Expedited SARS‐CoV‐2 Main Protease Inhibitor Discovery through Modular 'Direct‐to‐Biology' Screening.
Authors: Wilders, Harry1,2,3 (AUTHOR), Biggs, George2 (AUTHOR), Rowe, Sam M.1 (AUTHOR), Cawood, Emma E.2 (AUTHOR), Riziotis, Ioannis G.2 (AUTHOR), Rendina, Alan R.4 (AUTHOR), Grant, Emma K.1 (AUTHOR), Pettinger, Jonathan1,2 (AUTHOR), Fallon, David J.1 (AUTHOR), Skehel, Mark5 (AUTHOR), House, David1,2 (AUTHOR), Tomkinson, Nicholas C. O.3 (AUTHOR), Bush, Jacob T.1,2,3 (AUTHOR) Jacob.x.bush@gsk.com
Source: Angewandte Chemie. 2/3/2025, Vol. 137 Issue 6, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00448249
DOI:10.1002/ange.202418314